Searching journal content for articles similar to Wasserman et al. 20 (9): 1191.

Displaying results 1-6 of 6
For checked items
  1. ...of FOXA1 but increases the binding of AP-1. This latter increases enhancer activity. This E1 enhancer establishes a loop with the SOX9 genes in prostate cancer cells. Zhang et al. 1442 Genome Research www..org Risk variants mapping to noncoding regions may also directly impact unannotated transcripts...
  2. ..., Leunissen JAM. 2007. Primer3Plus, an enhancedweb interface to Primer3.Nucleic Acids Res 35: W71–W74. Wasserman NF, Aneas I, Nobrega MA. 2010. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res 20: 1191–1197. Wellbrock C, Rana...
  3. ....01). Interactions with a false discovery corrected P-value of >0.01 are not shown. Dryden et al. 1860 Genome Research www..org as targets of the 2q35, 9q31.2, and 8q24.21 risk loci. For the protein-coding genes IGFBP5,KLF4, andMYC, therewas some evidence that the tissue specificity of the interaction peaks...
  4. ...more CCAT2 transcript. Our results support a new mechanism of MYC and WNT regulation by the novel lncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk. [Supplemental material is available for this article.] Notwithstanding...
  5. ...differential in vivo activity to a MYC enhancer...
  6. ...and non-small cell lung adenocarcinomas (Ling et al. 2013; Redis et al. 2013; Qiu et al. 2014; Cai et al. 2015; Wang et al. 2015a,b; Zhang et al. 2015) and was shown to induce chromosomal instability and metastases in colon cancer by increasing MYC expression (Ling et al. 2013). Although these studies...
For checked items

Preprint Server